Sponsor pipeline

Neurodawn Pharmaceutical Co., Ltd. clinical trial pipeline

Get alerts when Neurodawn Pharmaceutical Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1
2
Phase 1/2
1
Phase 2
1
Phase 2/3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2/3
NCT07721545 Y-6 Sublingual Tablets for Acute Penetrating Artery Infarction Perforating Artery Infarction Not Yet Recruiting 2026-07-23
Phase 2
NCT07275762 Y-4 to Treat the Postherpetic Neuralgia Postherpetic Neuralgia Recruiting 2026-05-13
Phase 1/2
NCT07166380 RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction Transcranial Bone Marrow Injection Not Yet Recruiting 2025-09-30
Phase 1
NCT07618715 Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in U.S… Healthy Male and Female Subjects Not Yet Recruiting 2026-06-01
NCT07055412 Y-3 for Injection in Patients With Hepatic Insufficiency and Healthy Subjects Pharmacokinetic Differences Not Yet Recruiting 2025-07-08

Disease areas by active trials

Get alerts when Neurodawn Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free